Marketscreener, stock market website
02830be6763806a.ruYyiOMdS8zdEA39Mm9Jgwt-ZueK2Bm3ovxzmOaXBpw.-pFl27QtIojuT1LQXisWumE3CKT6jV7V0YYErIXufKSbvkTxqEp6jbBCQA
Logo MarketScreener
Back
Logo MarketScreener

Enter your password

Forgot your password ?
Subscribe
  • Markets
    Stocks
    Top Capitalization
    United States
    North America
    Europe
    Asia
    Middle East
    Sector Research
    Company Calendar
    Equity Analysis
    Most popular
    SPACEX (SPACE EXPLORATION TECHNOLOGIES)
    ADOBE INC.
    NVIDIA CORPORATION
    MICROSOFT CORPORATION
    MICRON TECHNOLOGY, INC.
    META PLATFORMS, INC.
    WELLS FARGO & COMPANY
    Indices
    Homepage
    Rankings
    Europe
    America
    Asia
    Africa
    Index Analysis
    Indices News
    S&P 500
    DOW JONES
    NASDAQ 100
    TSX COMP
    FTSE 100
    DAX
    CAC 40
    EURO STOXX 50
    Currency / Forex
    Homepage
    Rankings
    Currency Cross Rate
    Currency Converter
    Forex Analysis
    Currencies News
    USD / EUR
    USD / CAD
    USD / MXN
    USD / BRL
    USD / INR
    Commodities
    Homepage
    Energy
    Precious metals
    Agriculture
    Industrial Metals
    Livestock and Cattle
    GOLD
    CRUDE OIL (WTI)
    CRUDE OIL (BRENT)
    SILVER
    PLATINUM
    Cryptocurrencies
    Homepage
    Rankings
    Charts
    Analysis
    News
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    Interest Rates
    Homepage
    Yield Curve
    Developed Markets
    Emerging Markets
    ETF
    Summary
    Screener
    Analysis
    News
  • News
    All News
    Macroeconomics
    Policy
    Geopolitics
    Technology
    International Trade
    Military conflicts
    Taxation
    Sustainable development
    Legal, Regulation and Crime
    Companies
    Financial Results
    Analyst Recommendations
    Transcripts
    Press releases
    Insider transaction
    Controversies
    Innovations and expansions
    IPOs
    Rumors
    Activism
    Negative surprises
    Positive surprises
    New Contracts
    Indices
    Currency / Forex
    Commodities
    Cryptocurrencies
    ETF
    Interest Rates
    Funds
    Economy
    Sectors
    Most Read News
    Hot News
    Business Insiders
  • Analysis
    All Articles
    Must Read
    Equity Analysis
    Interviews
    Indices
    Currencies
    Commodities
    ETF
    Cryptocurrencies
  • Calendar
    Economic Calendar
    Company Calendar
    Dividend calendar
  • Stock Picks
    All our investments
    United States
    Europe
    Asia, Pacific
  • Portfolios
    USA Portfolio
    European Portfolio
    Asian Portfolio
    Virtual Portfolios
  • Watchlists
    My Watchlists
    Watchlists
    My previous session
    My most visited
    Most popular
    Investment Style
    Homepage
    Small caps
    Yield stocks
    Quality stocks at a reasonable price
    Multibaggers
    Undervalued stocks
    Top ROE
    Investment Themes
    Homepage
    The Internet of Things
    Semiconductors
    3D Printing
    Fintechs
    Sin stocks
    Outdoor
  • Trading
    Market Timing
    Hot News
    Pre/Post-Market Movers
    Technical Alerts
  • Screeners
    Stocks
    ETF
    Insider transactions
  • Tools
    Dynamic Chart
    Currency Converter
  • Rankings
    Top Movers
    Short-Term Gainers & Losers
    Long-term Gainers & Losers
    Unusual Volumes
    New Historical Highs
    New Historical Lows
    Pre/Post-Market Movers
    Top Fundamentals
    Fundamental Composite
    Sales Growth
    Earnings Growth
    Profitability
    Finances
    Visibility Rankings
    Rankings Valuation
    Valuation Composite
    Market Cap
    P/E Ratio
    Enterprise Value
    Yield
    Price to Book (PBR)
    Free Cash Flow (FCF)
    Top Consensus
    Consensus Composite
    Analyst Opinion
    Target Price
    Opinion Divergences
    Estimates Revisions
    Analyst Coverage
    Technical Analysis Rankings
    RSI
    GAPS
    STIM
    Daily Breakouts
    Weekly Breakouts
    Trends
    Volatility
    Top ranking ESG
    ESG MSCI
    Environment
    Social
    Governance
    Islamic Finance
    Paris Agreement
US Edition
Subscribe
  • Homepage
  • Markets
    • Stocks
      • Top Capitalization
      • United States
      • North America
      • Europe
      • Asia
      • Middle East
      • Sector Research
      • Company Calendar
      • Equity Analysis
      • Most popular
      • SPACEX (SPACE EXPLORATION TECHNOLOGIES)
      • ADOBE INC.
      • NVIDIA CORPORATION
      • MICROSOFT CORPORATION
      • MICRON TECHNOLOGY, INC.
      • META PLATFORMS, INC.
      • WELLS FARGO & COMPANY
    • Indices
      • Homepage
      • Rankings
      • Europe
      • America
      • Asia
      • Africa
      • Index Analysis
      • Indices News
      • S&P 500
      • DOW JONES
      • NASDAQ 100
      • TSX COMP
      • FTSE 100
      • DAX
      • CAC 40
      • EURO STOXX 50
    • Currency / Forex
      • Homepage
      • Rankings
      • Currency Cross Rate
      • Currency Converter
      • Forex Analysis
      • Currencies News
      • USD / EUR
      • USD / CAD
      • USD / MXN
      • USD / BRL
      • USD / INR
    • Commodities
      • Homepage
      • Energy
      • Precious metals
      • Agriculture
      • Industrial Metals
      • Livestock and Cattle
      • GOLD
      • CRUDE OIL (WTI)
      • CRUDE OIL (BRENT)
      • SILVER
      • PLATINUM
    • Cryptocurrencies
      • Homepage
      • Rankings
      • Charts
      • Analysis
      • News
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    • Interest Rates
      • Homepage
      • Yield Curve
      • Developed Markets
      • Emerging Markets
    • ETF
      • Summary
      • Screener
      • Analysis
      • News
  • News
    • All News
      • Macroeconomics
      • Policy
      • Geopolitics
      • Technology
      • International Trade
      • Military conflicts
      • Taxation
      • Sustainable development
      • Legal, Regulation and Crime
    • Companies
      • Financial Results
      • Analyst Recommendations
      • Transcripts
      • Press releases
      • Insider transaction
      • Controversies
      • Innovations and expansions
      • IPOs
      • Rumors
      • Activism
      • Negative surprises
      • Positive surprises
      • New Contracts
    • Indices
    • Currency / Forex
    • Commodities
    • Cryptocurrencies
    • ETF
    • Interest Rates
    • Funds
    • Economy
    • Sectors
    • Most Read News
    • Hot News
    • Business Insiders
  • Analysis
    • All Articles
    • Must Read
    • Equity Analysis
    • Interviews
    • Indices
    • Currencies
    • Commodities
    • ETF
    • Cryptocurrencies
  • Calendar
    • Economic Calendar
    • Company Calendar
    • Dividend calendar
  • Stock Picks
    • All our investments
    • United States
    • Europe
    • Asia, Pacific
  • Portfolios
    • USA Portfolio
    • European Portfolio
    • Asian Portfolio
    • Virtual Portfolios
  • Watchlists
    • My Watchlists
      • Watchlists
      • My previous session
      • My most visited
      • Most popular
    • Investment Style
      • Homepage
      • Small caps
      • Yield stocks
      • Quality stocks at a reasonable price
      • Multibaggers
      • Undervalued stocks
      • Top ROE
    • Investment Themes
      • Homepage
      • The Internet of Things
      • Semiconductors
      • 3D Printing
      • Fintechs
      • Sin stocks
      • Outdoor
  • Trading
    • Market Timing
    • Hot News
    • Pre/Post-Market Movers
    • Technical Alerts
  • Screeners
    • Stocks
    • ETF
    • Insider transactions
  • Tools
    • Dynamic Chart
    • Currency Converter
  • Rankings
    • Top Movers
      • Short-Term Gainers & Losers
      • Long-term Gainers & Losers
      • Unusual Volumes
      • New Historical Highs
      • New Historical Lows
    • Pre/Post-Market Movers
    • Top Fundamentals
      • Fundamental Composite
      • Sales Growth
      • Earnings Growth
      • Profitability
      • Finances
      • Visibility Rankings
    • Rankings Valuation
      • Valuation Composite
      • Market Cap
      • P/E Ratio
      • Enterprise Value
      • Yield
      • Price to Book (PBR)
      • Free Cash Flow (FCF)
    • Top Consensus
      • Consensus Composite
      • Analyst Opinion
      • Target Price
      • Opinion Divergences
      • Estimates Revisions
      • Analyst Coverage
    • Technical Analysis Rankings
      • RSI
      • GAPS
      • STIM
      • Daily Breakouts
      • Weekly Breakouts
      • Trends
      • Volatility
    • Top ranking ESG
      • ESG MSCI
      • Environment
      • Social
      • Governance
      • Islamic Finance
      • Paris Agreement
Switch edition
Stock 600329 TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
Add to a list

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Stocks

600329

CNE000001808

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
2026-06-12
5-day change 1st Jan Change
38.30 CNY +2.11% Intraday chart for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited -2.30% -16.05%
May. 20 Chinese State-Backed Entities to Dispose of Stake in Tianjin Pharmaceutical Da Ren Tang Unit via Public Tender MT
May. 15 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Appointment of Zhai Shuping as Independent and Non-Executive Director, Effective May 15, 2026 CI
Summary
Quotes
Charts
Technical Analysis Static Chart Total Return chart News Chart Sector Chart Comparison Chart Relative Strength Chart
News
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies
Company
Profile Governance Share ownership Insider transactions Connections
Financials
Analysts' Forecasts Income Statement Balance Sheet Cash flow Financial Ratios Business Segments
Valuation
Valuation ratios Dividend
Consensus
Analysts' Opinion Estimates Revisions
Ratings
Calendar
Sector
Sector performance Sector valuations Sector dividends Financial comparisons Sector ratings Sector consensus Sector revisions
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Tianjin Pharmaceutical Da Ren Tang posts qtrly revenue of RMB1.52 billion

Published on 04/29/2026 at 09:22 am EDT

Reuters
Share
LockThis article is reserved for members
Unlock the article: REGISTER NOW!
100% Free Registration
Already a customer? Log In
Reuters logo
© Reuters - 2026
Share

Latest news about Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

May. 20 Chinese State-Backed Entities to Dispose of Stake in Tianjin Pharmaceutical Da Ren Tang Unit via Public Tender MT
May. 15 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Appointment of Zhai Shuping as Independent and Non-Executive Director, Effective May 15, 2026 CI
May. 15 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Cessation of Liew Yoke Pheng Joseph as Independnet and Non-Executive Director, Chairman of the Audit Committee and A Member of the Remuneration Committee CI
Apr. 30 Singapore Shares Surge More Than 1% as DBS Books Record Total Income MT
Apr. 30 Tianjin Pharmaceuticals Da Ren Tang's Attributable Profit Jumps 13% in Q1; Shares Up 5% MT
Apr. 29 Tianjin Pharmaceutical Da Ren Tang posts qtrly revenue of RMB1.52 billion RE
Apr. 29 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Mar. 31 Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Drops 4.4% in 2025 MT
Mar. 31 Singapore Shares Remain in Red Amid Soaring Energy Costs; Rex International Plunges 20% MT
Mar. 30 Tianjin Pharmaceutical Da Ren Tang to Renew Financial Services Agreement with Tianjin Pharmaceutical Group Finance MT
Mar. 30 Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Down 4% in 2025 MT
Mar. 30 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Proposes Final Dividend for Fiscal Year 2025 CI
Mar. 30 Tianjin Pharmaceutical Da Ren Tang 2025 net profit down 4.4% RE
Mar. 30 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
Feb. 06 Controlling Shareholder Ups Stake in Tianjin Pharmaceutical Da Ren Tang; Shares Up 3% MT

Chart Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Chart Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329: Dynamic Chart

Company Profile

Logo Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a China-based company principally engaged in the research, development, manufacturing and retail of Chinese herbal medicines, Chinese patent medicines, chemical raw materials and preparations, and nutritional health products. The Company operates its businesses through three segments. The Chinese Patent Medicine segment is mainly engaged in the research, development, manufacturing and sales of Chinese medicines, including Su Xiao Jiu Xin Pill, Jing Wan Hong Ruan Gao, An Gong Niu Huang Pill, Qing Gong Shou Tao Pill and other products. The Western Medicine segment is mainly engaged in the research, development, manufacturing and sales of Western medicines. The Others segment mainly includes economic information consulting services, house leasing and other businesses. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
3,890
Sector
Pharmaceuticals
More about the company

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
38.30
Average target price
-
Consensus
EPS Estimates
Revisions to estimates

Annual profits - Rate of surprise

Company calendar
Indices Europe America Asia
My Watchlist
 

My lists
Rankings
 

More Rankings
Rankings
 

More Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

  1. Stock Market
  2. Stock Market News
  3. Tianjin Pharmaceutical Da Ren Tang posts qtrly revenue of RMB1.52 billion
Best financial portal

Best financial
portal

More than 20 yearsat your side

More than 20 years
at your side

Trustpilot
+ 1,300,000members

+ 1,300,000
members

Quick & easycancellation

Quick & easy
cancellation

Our Expertsare here for you

Our Experts
are here for you

Download from Apple Store

OUR EXPERTS ARE HERE FOR YOU

Monday - Friday 9am-12pm / 2pm-6pm GMT + 1

Contact us
MarketScreener, Stock Market Live
Legal information | Cookie settings | MarketScreener Blog | About us | Copyright © 2026 Surperformance SAS. All rights reserved.
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong